We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use an ethnographic study to evaluate your digital health product.
What animal by-products (ABPs) are, how to set up a site that uses them safely, the paperwork you need, and how to dispose of them.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Things to consider when buying and using products.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
How to use a cost benefit analysis to evaluate your digital health product.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
How to use a quasi-experimental study to evaluate your digital health product.
A summary of what delivering better integrated care means and how Monitor is supporting the sector.
How to ensure the products you make or import comply with the law and are safe for consumers to use.
How to begin with evaluating a digital health product, including when to evaluate, budgeting and getting support.
The requirements for 3D printed products will depend on whether they are classed as medical devices, personal protective equipment (PPE) or both.
Pharmacy, prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
Product Safety Report for Caro White Intensive Care Lightening Beauty Cream sold via eBay presenting a serious chemical risk.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
How to access social care, and support if you, or someone you care for is blind.
How to assess household and non-household packaging from 2024 onwards if you’re a UK organisation affected by extended producer responsibility (EPR) for packaging.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.